Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303
10/14/2026
Impact: 80
Healthcare
Stifel analyst Shlomo Rosenbaum has maintained a Buy rating on IQVIA Holdings (NYSE: IQV) and increased the price target from $276 to $303.
AI summary, not financial advice
Share: